SEC Form 4 · accession 0000943819-26-000050
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter C Farrell
Director
Period of report
Sep 2, 2026
Accepted (ET)
Sep 4, 2026 · 6:30 am EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Sep 2, 2026 | S | 970 | $234.73 | D | 51,803 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.